Shameze Rampertab

Shameze Rampertab currently works at Kane Biotech, Inc., as Director from 2025, Ancient Strains Ltd., as Independent Director, and Electro Metals & Mining, Inc. (Canada), as Independent Director & Chair-Audit Committee, EVP.
Mr. Rampertab also formerly worked at Imaging Dynamics Co. Ltd., as Chairman from 2011 to 2012, DRI Healthcare, as Finance Director, Zomedica Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Director, Zomedica Corp., as Chief Financial Officer, Secretary & Director in 2020, Cormark Securities, Inc., as Analyst, Sprott, Inc., as Health Sciences & Biotechnology Analyst, Intellipharmaceutics International, Inc., as CFO, VP-Finance & Head-Investor Relations in 2014, Canaccord Adams, as Analyst, Jennings Capital, Inc., as Senior Research Analyst from 2003 to 2008, Canaccord Capital Corp., as Health Sciences & Biotechnology Analyst, Loewen, Ondaatje, McCutcheon Ltd., as Partner, Profound Medical, Inc., as Chief Financial Officer, and Profound Medical Corp., as Chief Financial Officer & Secretary from 2014 to 2015.
Mr. Rampertab received his Masters Business Admin degree in 1991 from McMaster University.